Form D · Biotechnology
Heartflow, Inc.
Redwood City, CA · CIK 0001464521
Offering snapshot reported Jun 14, 2019 · SEC filing
- Reported sold
- $65M Offering amount: $100M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2019 | Initial | $64,999,952 | No comparison | 9 | SEC filing |
| Dec 4, 2017 | Initial | $89,999,983 | No comparison | 2 | SEC filing |
| May 20, 2016 | Amendment | $99,930,499 | $64,048,960vs Feb 12, 2015 | 25 | SEC filing |
| Feb 12, 2015 | Initial | $35,881,539 | No comparison | 16 | SEC filing |
| Feb 27, 2014 | Amendment | $104,699,896 | $39,699,956vs Dec 30, 2011 | 29 | SEC filing |
| Feb 2, 2012 | Amendment | $74,999,916 | $9,999,976vs Dec 30, 2011 | 18 | SEC filing |
| Dec 30, 2011 | Initial | $64,999,940 | No comparison | 15 | SEC filing |
| Feb 4, 2011 | Amendment | $20,416,022 | $6,300,000vs Sep 1, 2010 | 10 | SEC filing |
| Sep 1, 2010 | Initial | $14,116,022 | No comparison | 7 | SEC filing |
| Jun 14, 2010 | Initial | $10,000,000 | No comparison | 5 | SEC filing |
| Apr 19, 2010 | Initial | $1,600,000 | No comparison | 3 | SEC filing |
| Jul 10, 2009 | Initial | $195,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341906
Source: Form D, filed Jun 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eran Broshy | Director |
| Jesse Du Bey | Director |
| Noemi C. Espinosa | Executive |
| Noemi C. Espinoza | Executive |
| Thomas C. Hawes | Director |
| Tom Hawes | Director |
| Nicky Espinosa Hayes | Executive |
| Jeff Lightcap | Director |
| Dana Mead | Director, Executive |
| Robert Mitchell | Director |
| H. Baird Radford, Iii | Executive |
| Lonnie Smith | Director |
| John Stevens | Director |
| Casey Tansey | Director |
| Charles A. Taylor | Director, Executive |
| Barry Uphoff | Director |
| John R. Vrolyk | Director, Executive |
| Kent Walker | Director |
| William Weldon | Director |
| Philip M. Young | Director |
| Christopher K. Zarins | Director, Executive |
| Christopher K. Zarins, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1400 Seaport Blvd, Bldg. B
Redwood City, CA, 94063
Redwood City, CA, 94063